Mass Spectrometry for the&#160;Study of Autism and Neurodevelopmental Disorders (Q92192968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

title

Mass Spectrometry for the Study of Autism and Neurodevelopmental Disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Kelly L Wormwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

Armand G Ngounou Wetie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

Jeanne P Ryan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

Costel C Darie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

Alisa G Woods

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

Advances in Experimental Medicine and Biology

27 April 2020

number of pages

23

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

volume

1140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

477-499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

Proteomic approach for the elucidation of biological defects in autism

27 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A comparison of selected mRNA and protein abundances in human liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Mass spectrometry for the detection of potential psychiatric biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

One decade of salivary proteomics: current approaches and outstanding challenges.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Mark Twain: how to fathom the depth of your pet proteome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Human saliva proteome and transcriptome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The conundrums of understanding genetic risks for autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism as a strongly genetic disorder: evidence from a British twin study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A broader phenotype of autism: the clinical spectrum in twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Genetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Patterns and rates of exonic de novo mutations in autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Exploring Links between Genotypes, Phenotypes, and Clinical Predictors of Response to Early Intensive Behavioral Intervention in Autism Spectrum Disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Working up autism: the practical role of medical genetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Integrative gene network analysis provides novel regulatory relationships, genetic contributions and susceptible targets in autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism spectrum disorder in the genetics clinic: a review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The role of neurotrophic factors in autism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism: an emerging 'neuroimmune disorder' in search of therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Potential biomarkers in psychiatry: focus on the cholesterol system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

2-year-old boy who has been diagnosed with autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism from 2 to 9 years of age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

How useful are screening instruments for toddlers to predict outcome at age 4? General development, language skills, and symptom severity in children with a false positive screen for autism spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Neurochemical correlates of autistic disorder: a review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Absence of urinary opioid peptides in children with autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Opioid peptides and dipeptidyl peptidase in autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Lack of association between autism and four heavy metal regulatory genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Sulfhydryl-reactive metals in autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Blood mercury concentrations in CHARGE Study children with and without autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Proteomic research in psychiatry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

High complement factor I activity in the plasma of children with autism spectrum disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A novel blood-based biomarker for detection of autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Difference gel electrophoresis. A single gel method for detecting changes in protein extracts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Analysis of Proteins Using DIGE and MALDI Mass Spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A pilot proteomic study of protein markers in autism spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Protein signatures of oxidative stress response in a patient specific cell line model for autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism-specific maternal autoantibodies recognize critical proteins in developing brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Urinary protein patterns in autism as revealed by high resolution two-dimensional electrophoresis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Altered vascular phenotype in autism: correlation with oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Molecular and Cellular Aspects of Mental Retardation in the Fragile X Syndrome: From Gene Mutation/s to Spine Dysmorphogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Advances in the treatment of fragile X syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Early identification of autism in fragile X syndrome: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The behavioral phenotype of FMR1 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Fragile X Syndrome and Targeted Treatment Trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Behavioral Phenotype of Fragile X Syndrome in Adolescence and Adulthood

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

High MMP-9 activity levels in fragile X syndrome are lowered by minocycline

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The challenges of clinical trials in fragile X syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Outcome measures for clinical trials in fragile X syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Proteomic analysis reveals CCT is a target of Fragile X mental retardation protein regulation in Drosophila

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Stable isotope labeling with amino acids in Drosophila for quantifying proteins and modifications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Autism: the role of cholesterol in treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Smith-Lemli-Opitz syndrome and autism spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Cognitive and behavioral aspects of Smith-Lemli-Opitz syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Abnormalities of cholesterol metabolism in autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Smith-Lemli-Opitz syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Δ3-5/T93M) mouse: a model of Smith-Lemli-Opitz syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith-Lemli-Opitz syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The function of immunoglobulin A in immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Brief report: immunoglobulin A deficiency in a subset of autistic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

The lipocalin protein family: structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Perspectives in the study of thyroid hormone action on brain development and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Zinc alpha 2-glycoprotein: a multidisciplinary protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Human seminal plasma prolactin-inducible protein is an immunoglobulin G-binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_28

10.1007/978-3-030-15950-4_28

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347066 AND SRC:MED&resulttype=core&format=json

27 April 2020

1 reference